Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, tolerability, and immunogenicity of Haemophilus influenzae type b/Hepatitis B vaccine in healthy infants
2006-003648-46Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of haemophilus influenzae type b vaccine + hepatitis b vaccine in hepatitis B (HBV) and Haemophilus influenzae type b disease (Hib), sponsored by Merck & Co. Primary endpoint: Development of gastric and/or duodenal ulcers. Started Jan 2007; status: completed.
02
Drugs
haemophilus influenzae type b vaccine + hepatitis b vaccine
03
Conditions
hepatitis B (HBV)Haemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2006-003648-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003648-46.